News

The University of Kentucky has been selected as a site for a trial to assess dose levels of a Johnson & Johnson booster shot.

University of Kentucky alumnus Mosoka Fallah, Ph.D., is on the frontlines of the COVID-19 pandemic in Liberia.

The University of Kentucky Center of Excellence in Rural Health (UK CERH) and a network of community partners are joining forces to intensify efforts to increase vaccination rates in a 32-county region of Appalachia Kentucky and neighboring counties in West Virginia.

The book is edited by UK faculty members Dr. James W. Holsinger Jr. and Dr. F. Douglas Scutchfield.

A University of Kentucky team is linking with a nationally-known education innovator to move beyond what school was before the COVID-19 pandemic.

A new study led by UK virologist and College of Medicine Vice Dean for Research Becky Dutch reveals foundational characteristics of SARS-CoV-2's spike protein.

On this episode of "Behind the Blue," Rebecca Dutch from University of Kentucky’s Department of Molecular & Cellular Biochemistry joins UK Public Relations and Strategic Communications' Kody Kiser and UK Chief Communications Officer Jay Blanton to share her thoughts on a wide range of pandemic topics.

The project, funded by UK’s UNITE Research Priority Area, will enhance understanding of COVID-19 vaccine skepticism among populations historically less likely to become vaccinated.

As the COVID delta variant continues to spread across the United States, questions remain around both vaccine effectiveness and vaccination rates, and what these numbers could mean moving into the fall.

The research team hopes the study’s results will inform science-based decisions about mask use and social distancing after vaccination, especially as new variants spread and emerge.